BCM
ELV icon

Bridgeway Capital Management’s Elevance Health ELV Stock Holding History

Bridgeway Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,650
Closed -$858K – 1229
2024
Q3 		$858K Sell
1,650
-200
-11% -$107K 0.02% 728
2024
Q2 		$1M Sell
1,850
-5,250
-74% -$2.78M 0.02% 682
2024
Q1 		$3.68M Hold
7,100
– – 0.08% 381
2023
Q4 		$3.35M Buy
+7,100
New +$3.28M 0.07% 421
2020
Q4 		– Sell
-75,425
Closed -$20.3M – 1320
2020
Q3 		$20.3M Sell
75,425
-35,400
-32% -$9.53M 0.46% 61
2020
Q2 		$29.1M Sell
110,825
-18,625
-14% -$4.97M 0.59% 45
2020
Q1 		$29.4M Sell
129,450
-43,550
-25% -$11.9M 0.67% 39
2019
Q4 		$52.3M Buy
+173,000
New +$47.6M 0.7% 30
2018
Q1 		– Sell
-278,100
Closed -$62.6M – 1394
2017
Q4 		$62.6M Buy
278,100
+6,700
+2% +$1.43M 0.67% 35
2017
Q3 		$51.5M Buy
271,400
+36,500
+16% +$6.95M 0.59% 50
2017
Q2 		$44.2M Buy
234,900
+12,400
+6% +$2.23M 0.53% 69
2017
Q1 		$36.8M Buy
+222,500
New +$35.4M 0.45% 79
2016
Q1 		– Sell
-149,756
Closed -$20.9M – 1447
2015
Q4 		$20.9M Buy
149,756
+1,150
+0.8% +$158K 0.39% 78
2015
Q3 		$20.8M Hold
148,606
– – 0.44% 50
2015
Q2 		$24.4M Buy
148,606
+5,296
+4% +$846K 0.48% 32
2015
Q1 		$22.1M Buy
143,310
+37,800
+36% +$5.38M 0.46% 37
2014
Q4 		$13.3M Hold
105,510
– – 0.3% 72
2014
Q3 		$12.6M Buy
105,510
+17,600
+20% +$2.02M 0.32% 56
2014
Q2 		$9.46M Buy
87,910
+24,400
+38% +$2.51M 0.25% 69
2014
Q1 		$6.32M Buy
63,510
+10,500
+20% +$950K 0.18% 111
2013
Q4 		$4.9M Buy
53,010
+9,300
+21% +$826K 0.15% 134
2013
Q3 		$3.65M Buy
43,710
+35,210
+414% +$3.02M 0.12% 161
2013
Q2 		$696K Buy
+8,500
New +$636K 0.03% 793

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Bridgeway Capital Management's ELV Position: Q4 2024 in Review

Bridgeway Capital Management sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 1,650 shares — an estimated $858K sold.

Bridgeway Capital Management first reported a position in ELV in Q2 2013 and held it in 23 quarters. The position peaked at $62.6M in Q4 2017. 1,605 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Bridgeway Capital Management reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Bridgeway Capital Management sold 1,650 Elevance Health shares in Q4 2024, an estimated $858K.
  • Bridgeway Capital Management first reported a position in Elevance Health in Q2 2013 and held it in 23 quarters.
  • Bridgeway Capital Management's Elevance Health position peaked at $62.6M in Q4 2017.
  • 1,605 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Bridgeway Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.